SVP, CMO, Head-Res&Drug
Avg Cost/Share
$3.66
Shares
17,012
Total Value
$62,263.92
Owned After
521,425
SEC Form 4
SVP, CMO, Head-Res&Drug
Avg Cost/Share
$3.81
Shares
15,570
Total Value
$59,321.70
Owned After
521,425
SEC Form 4
SVP, CMO, Head-Res&Drug
Avg Cost/Share
$1.76
Shares
41,269
Total Value
$72,633.44
Owned After
521,425
SEC Form 4
CMO,SVP,Head-Res&Drug
Avg Cost/Share
$6.45
Shares
16,128
Total Value
$104,025.60
Owned After
521,425
SEC Form 4
CMO,SVP,Head-Res&Drug
Avg Cost/Share
$15.24
Shares
38,618
Total Value
$588,538.32
Owned After
521,425
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Shetzline Michael | IRWD | SVP, CMO, Head-Res&Drug | Feb 24, 2026 | Sell | $3.66 | 17,012 | $62,263.92 | 521,425 | |
| Shetzline Michael | IRWD | SVP, CMO, Head-Res&Drug | Feb 23, 2026 | Sell | $3.81 | 15,570 | $59,321.70 | 521,425 | |
| Shetzline Michael | IRWD | SVP, CMO, Head-Res&Drug | Feb 10, 2025 | Sell | $1.76 | 41,269 | $72,633.44 | 521,425 | |
| Shetzline Michael | IRWD | CMO,SVP,Head-Res&Drug | May 20, 2024 | Sell | $6.45 | 16,128 | $104,025.60 | 521,425 | |
| Shetzline Michael | IRWD | CMO,SVP,Head-Res&Drug | Feb 12, 2024 | Sell | $15.24 | 38,618 | $588,538.32 | 521,425 |